dearseq: a variance component score test for RNA-Seq differential analysis that effectively controls the false discovery rate - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles NAR Genomics and Bioinformatics Year : 2020

dearseq: a variance component score test for RNA-Seq differential analysis that effectively controls the false discovery rate

Abstract

RNA-seq studies are growing in size and popularity. We provide evidence that the most commonly used methods for differential expression analysis (DEA) may yield too many false positive results in some situations. We present dearseq, a new method for DEA which controls the FDR without making any assumption about the true distribution of RNA-seq data. We show that dearseq controls the FDR while maintaining strong statistical power compared to the most popular methods. We demonstrate this behavior with mathematical proofs, simulations, and a real data set from a study of Tuberculosis, where our method produces fewer apparent false positives.
Fichier principal
Vignette du fichier
635714.full.pdf (1.89 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-02138664 , version 1 (24-05-2019)

Identifiers

Cite

Marine Gauthier, Denis Agniel, Rodolphe Thiébaut, Boris Hejblum. dearseq: a variance component score test for RNA-Seq differential analysis that effectively controls the false discovery rate. NAR Genomics and Bioinformatics, 2020, 2 (4), pp.lqaa093. ⟨10.1093/nargab/lqaa093⟩. ⟨hal-02138664⟩
183 View
448 Download

Altmetric

Share

Gmail Facebook X LinkedIn More